Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin and caffeine effects on post-occlusive reactive hyperaemia
NL-OMON32791Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rosuvastatin and caffeine, sponsored by Radboud University Medical Center. Primary endpoint: Forearm blood flow. Started Mar 2009; status: active, not recruiting.
02
Drugs
rosuvastatincaffeine
Beyond the preview
Go deeper on NL-OMON32791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32791.